Search Results
Dec 02, 2025, 14:00 ET THE U.S. POINTER STRUCTURED HEALTHY LIFESTYLE PROGRAM -- PREVIOUSLY SHOWN TO IMPROVE COGNITION -- MAY ALSO IMPROVE SLEEP APNEA, BLOOD PRESSURE REGULATION, AND COGNITIVE RESILIENCE
benefits may help to support cognitive function and overall brain health in U.S. POINTER participants," said ancillary study Principal Investigators, Drs. Brinkley and Shaltout.POINTER-NeuroimagingPOINTER-Neuroimaging is the first large-scale investigation of how lifestyle interventions
More news about: Alzheimer's Association
Dec 02, 2025, 09:10 ET Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025
Image-Based Risk (Nov 30, 1:30–2:00 PM CST)A cross-disciplinary discussion featuring Drs. Graham Colditz, Joy Jiang, and Hari Trivedi, exploring how image-based risk complements traditional models and what this means for more personalized,
More news about: Lunit
Nov 28, 2025, 16:47 ET Strathcona Resources Ltd. Receives Court Approval for Special Distribution
book-entry accounts of registered shareholders' whose common shares are represented by DRS statement(s) without any further action by such registered shareholder and will provide such registered shareholder with an updated DRS statement(s) as soon as practicable after December 22, 2025. Registered shareholders
More news about: Strathcona Resources Ltd.
Nov 28, 2025, 06:00 ET HOYNE BANCORP, INC. ANNOUNCES EXPECTED CLOSING DATE OF CONVERSION AND STOCK OFFERING
shares of Common Stock issued and outstanding.Pacific Stock Transfer, the Company's transfer agent, expects to mail Direct Registration System ("DRS") Book-Entry statements for the shares of Common Stock purchased in the Subscription Offering, as well as refund and interest checks, on or about December
More news about: Hoyne Bancorp, Inc.
Nov 24, 2025, 05:19 ET Drs. Elliott Brea, Esther Redin, and Gavitt Woodard Announced as Recipients of LUNGevity's Career Development Awards
multimedia:https://www.prnewswire.com/news-releases/drs-elliott-brea-esther-redin-and-gavitt-woodard-announced-as-recipients-of-lungevitys-career-development-awards-302623788.htmlSOURCE
More news about: LUNGevity Foundation
Nov 21, 2025, 13:30 ET HMP Global Acquires Music City SCALE to Build the Industry's Most Comprehensive Learning Ecosystem in Aesthetic Medicine and Skin Health
with HMP Global's mission. We look forward to expanding SCALE's reach, unlocking new growth, and delivering even greater value to the community."Drs. Biesman and Gold will continue to guide SCALE's scientific direction and faculty engagement."Our goal has always been to create a truly multispecialty
More news about: HMP Global
Nov 20, 2025, 15:12 ET 2025 Double Helix Medals dinner raises over $7 million
Mrs. Jeanne Moutoussamy-Ashe, Ms. Jamie Nicholls and Mr. O. Francis Biondi, Mr. and Mrs. David Boies, Ms. Barbara Amonson and Dr. Vincent Della Pietra, Drs. Pamela Hurst-Della Pietra and Stephen Della Pietra, Mr. and Mrs. John M. Desmarais, Mr. and Mrs. Jeffrey E. Kelter, Dr. and Mrs. Tomislav Kundic, Mr.
More news about: Cold Spring Harbor Laboratory
Nov 19, 2025, 16:00 ET Lion Announces Plan to Implement ADS Ratio Change
receive one (1) new ADS in exchange for every thirteen (13) existing ADSs then-held. Holders of uncertificated ADSs in the Direct Registration System ("DRS") and in The Depository Trust Company ("DTC") will have their ADSs automatically exchanged and need not take any action. The exchange of every thirteen
More news about: Lion Group Holding Ltd.
Nov 19, 2025, 11:08 ET Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)
biotechnology company developing innovative anti-cancer drugs, today announced that patient dosing is underway in a clinical trial led by the renowned Drs. Elizabeth Stover, Joyce Liu, and Ursula Matulonis from the Dana-Farber Cancer Institute. Dr. Matulonis previously served as the Principal Investigator
More news about: Dialectic Therapeutics, Inc.
Nov 18, 2025, 12:01 ET ISMP Announces 28th Annual Cheers Award Recipients
4th edition of Safe Handling of Hazardous Drugs for the Oncology Nursing Society, a resource that is utilized by nurses all over the world. Drs. Olsen and Walton also each co-led the development of a Joint Position Statement on Safe Handling of Hazardous Drugs for the Oncology Nursing Society
More news about: Institute for Safe Medication Practices
Nov 13, 2025, 10:51 ET AMERICA 250: LANDMARK 2026 EXHIBITION REVEALS HOW RELIGIOUS FREEDOM AND ANTISEMITISM IMPACTED THE REVOLUTIONARY WAR AND AMERICA'S FOUNDING - IN AN UNTOLD TALE ABOUT JEWISH LIFE, THE CARIBBEAN, TRADE, AND THE HIGH SEAS DURING AMERICAN REVOLUTION
contexts." Dan Tadmor is available for interviews as are the exhibition's curator, Dr. Josh Perelman, and scholarly advisors Drs. Jonathan D. Sarna (Brandeis University, ret.), Pamela Nadell (American University), and Laura A. Leibman (Princeton University).
More news about: National Museum of American Jewish History
Nov 12, 2025, 10:07 ET Planet Smilez Returns to Alma Mater to Lead Workforce Development Symposium for Maryland Youth
to their alma mater, the University of Maryland School of Dentistry, to deliver the Discovering Dentistry Symposium (DDS). The program will be led by Drs. Kathryn Pawlak, Lauren Gritzer, Kristine Oladipo, and Nadine Mirza.
More news about: Planet Smilez
Nov 11, 2025, 11:11 ET Breakthrough Insights into Hemodynamics Featured in Journal of Cardiac Failure November Issue
on Hemodynamics, highlighting the renewed importance of cardiovascular physiology as a foundation for modern heart failure care. Guest edited by Drs. Susanna Mak (University of Toronto), Daniel Burkhoff (Cardiovascular Research Foundation), and Mark Belkin (University of Chicago), the issue explores
More news about: Heart Failure Society of America
Nov 11, 2025, 10:13 ET Olympus Corporation Announces Newest Appointments to Help Drive Innovation and Patient Safety for Respiratory Business
partnership with clinicians to identify and address unmet needs in respiratory care. Experienced and knowledgeable clinical practitioners and researchers like Drs. Gildea and Ötvös will ensure Olympus develops innovative medical devices while driving patient-focused value."
More news about: Olympus Corporation of the Americas
Nov 11, 2025, 08:54 ET Announcing the 2024-25 VIN Veritas Award Winners
Information Network (VIN) is delighted to present the 2024-25 VIN Veritas Award to the Copper Hepatopathy Action Group which includes: (in alphabetical order) Drs. Sharon Center, John Cullen, Keith Richter, David Twedt, Joe Wakshlag, Penny Watson, and Cynthia Webster. Established in 2020,
More news about: Veterinary Information Network
Nov 10, 2025, 14:34 ET Physician Growth Partners Guides Fox Valley Orthopedics Into Next Growth Chapter With Sequel Ortho Partnership
Founded in 1973 by Drs. Eugene Wittenstrom and Merle Denker, FVO has carried their pioneering spirit forward over the years and is now home to 20 physicians, 21 advanced practice
More news about: Sequel Ortho
Nov 10, 2025, 13:15 ET Physician Growth Partners Guides Fox Valley Orthopedics Into Next Growth Chapter With Sequel Ortho Partnership
Founded in 1973 by Drs. Eugene Wittenstrom and Merle Denker, FVO has carried forward their pioneering spirit and is now home to 20 physicians, 21 advanced practice providers,
More news about: Physician Growth Partners
Nov 10, 2025, 11:04 ET DISTINGUISHED CANCER RESEARCHER STUART S. MARTIN, PHD, NAMED CHAIR OF THE DEPARTMENT OF PHARMACOLOGY & PHYSIOLOGY AT UM SCHOOL OF MEDICINE
Mark T. Gladwin, MD, announced today. As the distinguished Drs. Angela and Harry Brodie Professor of Translational Cancer Research, Dr. Martin has served as Interim Chair of the Department over the past year. He
More news about: University of Maryland School of Medicine
Nov 05, 2025, 13:41 ET Drug Hunter, Inc. Announces the Appointment of Dr. Lori Friedman, Ph.D., to its Scientific Advisory Board
drug discovery R&D teams, today announced the appointment of Dr. Lori Friedman, Ph.D., to its scientific advisory board (SAB). Dr. Friedman joins Drs. Wendy Young, Ph.D.; Dean Brown, Ph.D.; Nicholas Meanwell, Ph.D.; Daniel Erlanson, Ph.D.; and Ken Brameld, Ph.D. in aiding the management team to empower
More news about: Drug Hunter
Nov 05, 2025, 10:57 ET Late-Breaking Clinical Trial Results Announced at VIVA 2025
drug-eluting resorbable scaffold (DRS) vs percutaneous transluminal angioplasty (PTA) in patients with chronic limb-threatening ischemia (CLTI) and infrapopliteal artery disease. This presentation highlights 3-year clinical outcomes and subgroup analyses. At 3 years, DRS demonstrated a 33% relative
More news about: The VIVA Foundation
Nov 05, 2025, 07:00 ET NCH Becomes First U.S. Hospital to Use AI That Detects Hidden Heart Attack Risk a Decade in Advance
collaboration coincides with Caristo Diagnostics' upcoming symposium at the American Heart Association (AHA) Scientific Sessions 2025, where experts including Drs. Orringer and Wang will discuss how imaging and AI are changing the way clinicians detect and manage coronary disease.
More news about: CARISTO DIAGNOSTICS
Nov 04, 2025, 14:47 ET ADLM releases new guidance on coagulation testing to improve care for patients on blood thinners
approach these scenarios thoughtfully, as this requires discretion to determine appropriate and optimal timing for testing," wrote the document authors Drs. Lindsay A.L. Bazydlo, Maximo J. Marin, Anna E. Merrill, Louise M. Man, Olajumoke O. Oladipo, and Neil S. Harris. "Communication and collaboration with
More news about: Association for Diagnostics & Laboratory Medicine (ADLM)
Nov 03, 2025, 16:37 ET ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION
issue a direct registration advice(s) (DRS) representing their post-consolidation common shares. The Company's registered shareholders whose common shares are represented by a DRS statement will not be required to complete and sign a letter of transmittal, and a DRS statement representing their post-consolidation
More news about: Else Nutrition Holdings Inc.
Oct 30, 2025, 07:30 ET Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal
potentially extend survival for patients with metastatic disease," said Lewis H. Bender, Founder, President, and CEO of Intensity Therapeutics, Inc. "As Drs. Thomas and El-Khoueiry noted, our paper reports that INT230-6 injected into visible tumors in metastatic patients at an amount based on the size of
More news about: Intensity Therapeutics Inc.
Oct 29, 2025, 13:27 ET Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress
promising therapeutic target in reproductive medicine, offering potential avenues for preserving pregnancy in the face of inflammatory challenges," said Drs. Kwak-Kim and Dambaeva. "However, increased levels of IL-22 could be associated with reproductive failures, emphasizing the delicate balance required
More news about: Rosalind Franklin University of Medicine and Science